Kraus Carl N 4
4 · Aquestive Therapeutics, Inc. · Filed Aug 12, 2024
Insider Transaction Report
Form 4
Kraus Carl N
Chief Medical Officer
Transactions
- Tax Payment
Common Stock
2024-08-09$3.43/sh−10,819$37,109→ 251,681 total
Footnotes (1)
- [F1]Represents shares withheld by the Issuer to satisfy the Reporting Person's tax withholding obligation in connection with the vesting of certain Restricted Stock Units ("RSUs") previously granted to the Reporting Person.